BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salavrakos M, Leclercq S, De Timary P, Dom G. Microbiome and substances of abuse. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110113. [PMID: 32971216 DOI: 10.1016/j.pnpbp.2020.110113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng D, Su H, Song Y, Chen T, Sun Q, Jiang H, Zhao M. Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder. Front Cell Infect Microbiol 2021;11:783917. [PMID: 34869080 DOI: 10.3389/fcimb.2021.783917] [Reference Citation Analysis]
2 Calleja-Conde J, Echeverry-Alzate V, Bühler KM, Durán-González P, Morales-García JÁ, Segovia-Rodríguez L, Rodríguez de Fonseca F, Giné E, López-Moreno JA. The Immune System through the Lens of Alcohol Intake and Gut Microbiota. Int J Mol Sci 2021;22:7485. [PMID: 34299105 DOI: 10.3390/ijms22147485] [Reference Citation Analysis]
3 Misiak B, Samochowiec J, Marlicz W, Łoniewski I. Gut microbiota in psychiatric disorders: Better understanding or more complexity to be resolved? Prog Neuropsychopharmacol Biol Psychiatry 2021;110:110302. [PMID: 33713733 DOI: 10.1016/j.pnpbp.2021.110302] [Reference Citation Analysis]
4 Lucerne KE, Osman A, Meckel KR, Kiraly DD. Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 2021;192:108598. [PMID: 33965398 DOI: 10.1016/j.neuropharm.2021.108598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ayoub SM, Piscitelli F, Silvestri C, Limebeer CL, Rock EM, Smoum R, Farag M, de Almeida H, Sullivan MT, Lacroix S, Boubertakh B, Nallabelli N, Lichtman AH, Leri F, Mechoulam R, Di Marzo V, Parker LA. Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators. Front Pharmacol 2021;12:706703. [PMID: 34603019 DOI: 10.3389/fphar.2021.706703] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]